- Investor's Business Daily•2 days ago
Galenica, whose joint venture with Fresenius has rights to Relypsa's drug Veltassa, is taking full ownership.
After hours: 30.54-0.59 (-1.91%) as of 5:16 PM EDT
|Bid||31.12 x 23100|
|Ask||31.13 x 14400|
|52wk Range||26.97 - 34.88|
|Day's Range||30.40 - 31.23|
|Avg Vol (3m)||5,053,734|
As of 4:03 PM EDT. Market closed.